Search

Search Constraints

You searched for: Author/Creator Kane, Steven

Search Results

3. Beyond adverse outcome pathways: making toxicity predictions from event networks, SAR models, data and knowledge. Issue 1 (22nd January 2021)

8. Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy. Issue 1 (24th November 2020)

9. Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy. Issue 1 (24th November 2020)

10. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Issue 1 (January 2022)